BioAdaptives, Inc.
BDPT
$0.00
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -9.09% | -47.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.09% | -47.12% | |||
| Cost of Revenue | -50.00% | -50.00% | |||
| Gross Profit | 2.44% | -46.05% | |||
| SG&A Expenses | -0.45% | -21.01% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.74% | -21.20% | |||
| Operating Income | 0.50% | 20.11% | |||
| Income Before Tax | 235.10% | 86.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 235.10% | 86.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 235.10% | 86.51% | |||
| EBIT | 0.50% | 20.11% | |||
| EBITDA | 0.51% | 20.24% | |||
| EPS Basic | 213.98% | 86.40% | |||
| Normalized Basic EPS | 201.72% | 86.94% | |||
| EPS Diluted | 105.38% | 86.40% | |||
| Normalized Diluted EPS | 105.17% | 86.94% | |||
| Average Basic Shares Outstanding | 18.19% | -0.18% | |||
| Average Diluted Shares Outstanding | 2,241.60% | -0.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||